Composition
- Active ingredients
- LIRAGLUTIDE 18MG/3ML (6MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LIRAGLUTIDE 18MG/3ML (6MG/ML) · SolutionANDA215503-001 · Prescription
- LIRAGLUTIDE 18MG/3ML (6MG/ML) · SolutionANDA217063-001 · Prescription
- LIRAGLUTIDE 18MG/3ML (6MG/ML) · SolutionANDA215421-001 · Prescription
- LIRAGLUTIDE 18MG/3ML (6MG/ML) · SolutionThis page
- LIRAGLUTIDE 18MG/3ML (6MG/ML) · SolutionANDA217234-001 · Prescription
- LIRAGLUTIDE 18MG/3ML (6MG/ML) · SolutionANDA214568-001 · Prescription
- LIRAGLUTIDE 18MG/3ML (6MG/ML) · SolutionANDA217590-001 · Prescription
- LIRAGLUTIDE 18MG/3ML (6MG/ML) · SolutionANDA215245-001 · Prescription
- LIRAGLUTIDE 18MG/3ML (6MG/ML) · SolutionANDA218115-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA212552.
At a glance
- Brand name
- Liraglutide
- Route
- Subcutaneous
- Dosage form
- Solution
- Applicant
- Fresenius Kabi USA
- Status
- Prescription
- FDA approval
- 30 Mar 2026
- Application
- ANDA212552-001